Clinical trial
Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
NCT05852587 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- January 1, 2033
- Enrollment
- 99 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clostridioides difficile infection, inflammatory bowel diseases